Publications by authors named "N Feu"
Corrigendum to "Lung function decline in people with serious mental illness: A call to action" [European Neuropsychopharmacology (2024) 41-46/ ENP-24-342].
Eur Neuropsychopharmacol
January 2025
This prospective observational study aimed to evaluate the rate of change in forced expiratory volume in the first second (FEV1) and to explore the factors associated with changes in FEV1 in people with serious mental illness (SMI). Sixty subjects diagnosed with schizophrenia or bipolar disorder who were smokers and without history of respiratory illness agreed to participate. The mean (range) follow-up period was 3.
View Article and Find Full Text PDFPeople with serious mental illness (SMI), such as schizophrenia and bipolar disorder, have a higher risk of premature morbidity and mortality. In the general population, impaired lung function is associated with increased morbidity and mortality. We compared lung function between people with and without serious mental illnesses using a cross-sectional study in 9 community mental health units.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates how the lung's diffusing capacity for carbon monoxide (Dlco) changes over time in patients with Chronic Obstructive Pulmonary Disease (COPD) and identifies factors that might affect this change, particularly focusing on sex differences.
- Results showed that COPD patients experience a more significant decline in Dlco compared to those without COPD, with an average yearly drop of 1.34% in COPD patients versus only 0.04% in controls.
- Women with COPD exhibited lower initial Dlco values and a steeper annual decline compared to men, indicating that sex may play a crucial role in how lung function deteriorates in these patients.
Background: This study has two main objectives: to describe the prevalence of undetected chronic obstructive pulmonary disease (COPD) in a clinical sample of smokers with severe mental illness (SMI), and to assess the value of the Tobacco Intensive Motivational Estimated Risk tool, which informs smokers of their respiratory risk and uses brief text messages to reinforce intervention.
Method: A multicenter, randomized, open-label, and active-controlled clinical trial, with a 12-month follow-up. Outpatients with schizophrenia (SZ) and bipolar disorder were randomized either to the experimental group-studied by spirometry and informed of their calculated lung age and degree of obstruction (if any)-or to the active control group, who followed the 5 A's intervention.